Palantir Technologies has now given back 5% over the past month to $128.47, with the stock drifting lower even as the Wolfe Research capitulation last week removed one active bear from the field.
The most telling signal this week is insider activity, and it points in one direction. An independent director, Alex Moore, sold across five separate tranches on June 15 alone — totalling around 16,000 shares worth roughly $2.1 million at prices between $130 and $135. CEO Alex Karp added another $2.3 million in sales on May 20. The Chief Accounting Officer has sold twice in the past month. On a net 90-day basis, insiders have collectively disposed of more than $124 million in stock. Significance scores on these trades are low, consistent with pre-planned selling programmes rather than discretionary exits — but the volume and timing, as the stock retreats from its highs, is worth noting.
The lending market offers no counterargument to the pressure: there is nothing remotely squeezed about the borrow picture. Availability is extraordinarily loose, running at over 8,200% — meaning the pool of shares available to borrow dwarfs actual short interest by a factor of more than 80. Short interest itself remains modest at 3% of free float, up roughly 9% over the past month but still too small to generate any meaningful covering dynamic. Cost to borrow is a negligible 0.45%, down from last week. Options positioning has actually shifted more bullish, with the put/call ratio at 0.93, roughly 1.3 standard deviations below its 20-day average — call demand has been running above the recent norm even as the stock slides. The combination points to a market that is not fearful of in the near term, simply less enthusiastic.
The Street remains as divided as it was last week, with no meaningful change in the underlying picture since the June 16 Wolfe upgrade. Bulls at Wedbush and Rosenblatt sit on targets of $225–$230, more than 75% above the current price. RBC stays at $90 with an Underperform. The formal consensus is hold, and the March 2026 as-of date on the broader consensus data means it may not fully reflect the post-Q1 reset in sentiment. Valuation remains the central tension: the P/E is 73x and EV/EBITDA is 53x, both compressing modestly over the past month as earnings estimates inch higher — EPS momentum ranks in the 86th percentile over 90 days — but the absolute multiples still price in a growth trajectory that leaves little room for disappointment. The ORTEX stock score holds near 74, with quality the standout (strong FCF margins, a Piotroski F-Score of 7) and value the persistent drag at just 26, reflecting an EV/EBIT above 150x.
Among correlated peers, the week has been broadly weak. NOW fell nearly 8% and GWRE dropped 9%, while APP was off around 2%. PLTR's 2% weekly decline is actually a relative hold in that context — the AI software cohort took a broader hit — which makes the magnitude of its own selling less alarming but does little to reset the longer-term drift lower from the May highs above $160.
The next hard catalyst is Q2 earnings, scheduled for August 3. The two most recent earnings prints both produced immediate one-day declines of 5–7%, with five-day moves of -5% to -14% — a pattern that suggests the market has been raising the bar into each report and then selling the reaction regardless of headline figures. With the stock now 20% below those May highs, how much of that bar has been lowered is the question worth tracking heading into August.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
